Timothy A Blenkinsop

Timothy A Blenkinsop is an Associate Professor at the Icahn School of Medicine at Mount Sinai, affiliated with the Department of Ophthalmology and Cell, Developmental & Regenerative Biology. His research focuses on retinal regeneration, particularly the biology of the retinal pigment epithelium (RPE), with an emphasis on developing in vitro disease models, epigenetic profiling, and transplantation strategies for RPE-related pathologies.

• Education:
  • PhD in Developmental Biology, New York University
  • BS in Cell Biology, University of Wisconsin at Whitewater

His work bridges regenerative medicine and translational ophthalmology, with key contributions to understanding RPE dysfunction in diseases like Age-Related Macular Degeneration (AMD) and Proliferative Vitreoretinopathy (PVR). Recent publications highlight advancements in stem cell-derived RPE therapy, contractility inhibition, and viral ocular infection models.

Dr. Blenkinsop's laboratory develops 3D eye organoids, epigenetic profiling tools, and NRF2 signaling modulators to address retinal degeneration. His research has implications for therapeutic development, including preclinical models and biofunctional polymers to prevent retinal scarring.

Office Location: Annenberg Building, Floor 22, Room A22-08, 1468 Madison Ave, New York, NY 10029.